hydroxychloroquine has been researched along with Psoriasis Arthropathica in 9 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Steroids and hydroxychloroquine remain the most widely prescribed treatment options in pregnancy, but the use of biologic agents is becoming increasingly common." | 3.83 | Brief Report: Patterns and Secular Trends in Use of Immunomodulatory Agents During Pregnancy in Women With Rheumatic Conditions. ( Bateman, BT; Desai, RJ; Gopalakrishnan, C; Hernandez-Diaz, S; Huybrechts, KF; Kim, SC; Mogun, H; Patorno, E, 2016) |
| "Rheumatic diseases were IA (60%) and CTD (40%)." | 1.56 | Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study. ( Alvaro-Gracia, JM; Blanco, R; Carmona, L; Castrejón, I; Fernández Fernández, D; Fernandez-Nebro, A; Galindo, M; Gonzalez-Gay, MA; Lledó, A; Manrique-Arija, S; Martinez-Lopez, D; Mena Vázquez, N; Mera-Varela, A; Pablos, JL; Retuerto, M, 2020) |
| "Hydroxychloroquine was inadequately effective and poorly tolerated." | 1.31 | Use of disease-modifying antirheumatic drugs in patients with psoriatic arthritis. ( Beaurain, D; Delcambre, B; Duquesnoy, B; Flipo, RM; Grardel, B; Marguerie, L, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 3 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Nuño, L | 1 |
| Novella Navarro, M | 1 |
| Bonilla, G | 1 |
| Franco-Gómez, K | 1 |
| Aguado, P | 1 |
| Peiteado, D | 1 |
| Monjo, I | 1 |
| Tornero, C | 1 |
| Villalba, A | 1 |
| Miranda-Carus, ME | 1 |
| De Miguel, E | 1 |
| Bogas, P | 1 |
| Castilla-Plaza, A | 1 |
| Bernad-Pineda, M | 1 |
| García-Lorenzo, E | 1 |
| Rodríguez-Araya, T | 1 |
| Balsa, A | 1 |
| Montero, F | 1 |
| Martínez-Barrio, J | 1 |
| Serrano-Benavente, B | 1 |
| González, T | 1 |
| Rivera, J | 1 |
| Molina Collada, J | 1 |
| Castrejón, I | 2 |
| Álvaro-Gracia, J | 1 |
| Pablos, JL | 1 |
| Galindo, M | 1 |
| Carmona, L | 1 |
| Lledó, A | 1 |
| Retuerto, M | 1 |
| Blanco, R | 1 |
| Gonzalez-Gay, MA | 1 |
| Martinez-Lopez, D | 1 |
| Alvaro-Gracia, JM | 1 |
| Fernández Fernández, D | 1 |
| Mera-Varela, A | 1 |
| Manrique-Arija, S | 1 |
| Mena Vázquez, N | 1 |
| Fernandez-Nebro, A | 1 |
| Barnes, AC | 1 |
| Bhavsar, KV | 1 |
| Weber, ML | 1 |
| Witkin, AJ | 1 |
| Zisman, D | 1 |
| Bitterman, H | 1 |
| Shalom, G | 1 |
| Feldhamer, I | 1 |
| Comanesther, D | 1 |
| Batat, E | 1 |
| Greenberg-Dotan, S | 1 |
| Cohen, S | 1 |
| Cohen, AD | 1 |
| Desai, RJ | 1 |
| Huybrechts, KF | 1 |
| Bateman, BT | 1 |
| Hernandez-Diaz, S | 1 |
| Mogun, H | 1 |
| Gopalakrishnan, C | 1 |
| Patorno, E | 1 |
| Kim, SC | 1 |
| Contreras Blasco, MA | 1 |
| Marguerie, L | 1 |
| Flipo, RM | 1 |
| Grardel, B | 1 |
| Beaurain, D | 1 |
| Duquesnoy, B | 1 |
| Delcambre, B | 1 |
| Sayers, ME | 1 |
| Mazanec, DJ | 1 |
1 review available for hydroxychloroquine and Psoriasis Arthropathica
| Article | Year |
|---|---|
[Erosive or inflammatory osteoarthritis: the great unknown].
Topics: Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Psoriatic; Diagnosis, Differential; Finge | 2007 |
8 other studies available for hydroxychloroquine and Psoriasis Arthropathica
| Article | Year |
|---|---|
Clinical course, severity and mortality in a cohort of patients with COVID-19 with rheumatic diseases.
Topics: Adult; Aged; Antirheumatic Agents; Antiviral Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Az | 2020 |
Coronavirus disease 2019 (COVID-19) in autoimmune and inflammatory conditions: clinical characteristics of poor outcomes.
Topics: Aged; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Antiviral Agen | 2020 |
Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study.
Topics: Adenosine Monophosphate; Age Factors; Aged; Alanine; Antiviral Agents; Arthritis, Psoriatic; Arthrit | 2020 |
A subtle case of hydroxychloroquine retinopathy: spectral domain optical coherence tomography findings.
Topics: Antirheumatic Agents; Arthritis, Psoriatic; Female; Humans; Hydroxychloroquine; Middle Aged; Retina; | 2014 |
Psoriatic arthritis treatment and the risk of herpes zoster.
Topics: Adalimumab; Adult; Aged; Antirheumatic Agents; Arthritis, Psoriatic; Azathioprine; Cyclosporine; Dru | 2016 |
Brief Report: Patterns and Secular Trends in Use of Immunomodulatory Agents During Pregnancy in Women With Rheumatic Conditions.
Topics: Adrenal Cortex Hormones; Adult; Antirheumatic Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; B | 2016 |
Use of disease-modifying antirheumatic drugs in patients with psoriatic arthritis.
Topics: Adolescent; Adult; Aged; Antirheumatic Agents; Arthritis, Psoriatic; Drug Combinations; Female; Gluc | 2002 |
Use of antimalarial drugs for the treatment of psoriatic arthritis.
Topics: Arthritis, Psoriatic; Chloroquine; Humans; Hydroxychloroquine; Retrospective Studies | 1992 |